ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      83.11
      -0.02%
      Bitcoin
      64,137.56
      0.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Compass Therapeutics Inc (CMPX)

      7. Compass Therapeutics Inc (CMPX) News

      CMPX

      Compass Therapeutics (CMPX)

      Compass Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CMPX
      DateTimeSourceHeadlineSymbolCompany
      04/25/20248:00AMGlobeNewswire Inc.Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously TreatedNASDAQ:CMPXCompass Therapeutics Inc
      04/16/20248:00AMGlobeNewswire Inc.Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid TumorsNASDAQ:CMPXCompass Therapeutics Inc
      04/12/20248:00AMGlobeNewswire Inc.Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual ConferenceNASDAQ:CMPXCompass Therapeutics Inc
      04/10/20248:00AMGlobeNewswire Inc.Compass Therapeutics to Participate in the Stifel Targeted Oncology DaysNASDAQ:CMPXCompass Therapeutics Inc
      04/09/202412:00PMGlobeNewswire Inc.Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPXCompass Therapeutics Inc
      03/21/20249:00AMGlobeNewswire Inc.Compass Therapeutics Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
      03/11/202410:12AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
      02/29/20248:00AMGlobeNewswire Inc.Compass Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:CMPXCompass Therapeutics Inc
      02/28/20248:00AMGlobeNewswire Inc.Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical TrialNASDAQ:CMPXCompass Therapeutics Inc
      02/14/202412:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
      02/09/202412:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
      01/10/202410:31AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
      01/09/20245:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
      01/05/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
      01/05/20248:00AMGlobeNewswire Inc.Compass Therapeutics Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
      11/21/20232:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
      11/09/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
      11/09/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
      11/09/20237:30AMGlobeNewswire Inc.Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
      11/07/20238:00AMGlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
      08/30/20238:00AMGlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
      08/03/20238:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
      08/03/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
      08/03/20238:00AMGlobeNewswire Inc.Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
      06/22/20234:05PMGlobeNewswire Inc.Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® IndexesNASDAQ:CMPXCompass Therapeutics Inc
      06/01/202310:06AMGlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
      05/04/20238:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPXCompass Therapeutics Inc
      05/04/20238:30AMGlobeNewswire Inc.Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
      04/27/20234:26PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CMPXCompass Therapeutics Inc
      04/26/20238:30AMGlobeNewswire Inc.Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQNASDAQ:CMPXCompass Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CMPX